Cargando…
Efficacy and safety of S-1 maintenance therapy in advanced non-small-cell lung cancer patients
BACKGROUND: Previous reports have demonstrated that S-1 has remarkable effects in the maintenance treatment of advanced non-small-cell lung cancer (NSCLC), and has less toxic and side effects than conventional drugs. AIM: To investigate the efficacy and safety of S-1 maintenance therapy in patients...
Autores principales: | Cheng, Xiao-Wei, Leng, Wen-Hua, Mu, Chun-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674711/ https://www.ncbi.nlm.nih.gov/pubmed/33269253 http://dx.doi.org/10.12998/wjcc.v8.i21.5172 |
Ejemplares similares
-
Prognostic role of multiple abnormal genes in non-small-cell lung cancer
por: Yan, Lu-Da, et al.
Publicado: (2022) -
Clinical efficacy and safety of nimotuzumab plus chemotherapy in patients with advanced colorectal cancer: a retrospective analysis
por: Bai, Sai-xi, et al.
Publicado: (2020) -
Histological transformation of non-small cell lung cancer: Clinical analysis of nine cases
por: Jin, Cai-Bao, et al.
Publicado: (2021) -
Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma: A retrospective, real-world study conducted in China
por: Wang, Dong-Xu, et al.
Publicado: (2020) -
Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma
por: Luo, Shi-Hua, et al.
Publicado: (2019)